Delivering Big Ideas from ASH 2025
Fellowship Training That Goes Where You Go
Dana-Farber, Gustave Roussy to Host Fifth Transatlantic Exchange in Oncology Focused on Cancer Drug Innovation
Fox Chase Fellows Shape the World of Cancer Care
Making Breakthroughs in ALL From Youth to Adulthood
Unconventional and Exceptional: Dr. Lee’s Fox Chase Residency
Cell-Death Safety Net a Potential New Cancer Target
Dana-Farber Launches Colorectal Cancer Screening Program in Central Asia
Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma
Defeating Cancer Means Never Resting on Our Laurels
Dana-Farber’s Largest Single Gift Advances Planned Cancer Hospital for New England
Temple Health Appoints Alex Khariton, MBA, as Chief Operating Officer of Fox Chase Cancer Center
Three Dana-Farber Cancer Institute scientific leaders elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026
Taming Chronic Inflammation
Addition of CDK 4/6 inhibitor benefits patients with HR+, HER2+ metastatic breast cancer, new study shows
Showing 16 - 30 of 1027 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
